DCAI

Overview

Highlights

News

Chart

Contacts

 

   
 
   
"Dialysis Corporation of America partners with physicians and hospitals to build and operate dialysis centers focused on delivering consistently high quality care to patients with failed kidney function."   
   
   
Approximate Financial Snapshot as of 1/7/08
Shares Outstanding 9.6M
52 Wk Hi/Lo 14.16/

7.70

Market Cap $77.3M
Recent Price $8.05

 

 

Join the SmallCapReview mailing list
Email:

 

1/7/08

Dialysis Corporation of America (DCAI)

Website: www.dialysiscorporation.com

A synergistic approach to sound medical and business practices.


Overview

Dialysis Corporation of America (Nasdaq: DCAI) through its subsidiaries, engages in the development and operation of outpatient kidney dialysis centers in the United States and internationally. It offers outpatient hemodialysis services, home dialysis services, inpatient dialysis services, and ancillary services associated with dialysis treatments.

The company provides dialysis and ancillary services to patients suffering from chronic kidney failure, also known as end-stage renal disease. It also offers acute inpatient dialysis treatments in hospitals, homecare services, and dialysis center management services. 

DCAI owns 35 free standing kidney hemodialysis centers in Pennsylvania, New Jersey, Georgia, Ohio, Maryland, Virginia and South Carolina. In addition, Dialysis Corporation distributes medical products, primarily disposables and diabetic supplies to hospitals, blood banks, laboratories, and retail pharmacies, as well as offers a line of blood lancets used to draw blood for testing.  

DCAI partners with physicians and hospitals providing the needed balance to consistently deliver high quality care to patients with failed kidney function.

To assist with effective and efficient operations management, DCAI provides clinical, regulatory and technical services, billing and reimbursement, general accounting, human resources, information systems, purchasing and marketing. Optimal size and flexibility are advantages DCAI brings to every strategic business relationship. 


DCAI Investor Highlights

  • Announced the acquisition of a majority interest in a dialysis center Georgia. The center has a total of 16 treatment stations, and a patient census of approximately 77 patients.
  • Owns 35 free standing kidney hemodialysis centers in Pennsylvania, New Jersey, Georgia, Ohio, Maryland, Virginia and South Carolina.
  • Operating revenues for the third quarter were $19.1 M compared to $16.5 M for the same period last year, a 16% increase.
  • Net income for the third quarter was $927,000 or $.10 per share compared to $814,000 or $.09 per share for the same period last year.
  • Operating revenues for the first nine months of 2007 were $54.5 M compared to $44.2 M for the same period last year.
  • Net income for the first nine months of 2007 was $2.0 M or $.22 per share compared to $1.9 M or $.20 per share for the same period last year.

Recent News and Press Releases

Dialysis Corporation of America Announces Opening of New Dialysis Center in Ohio

Dialysis Corporation of America Announces Acquisition of Georgia Dialysis Center

Dialysis Corporation of America Reports Third Quarter 2007 Results

For the latest Quote and News on DCAI Click Here.


Three Month Chart

 


Contacts

Dialysis Corp. of America
1302 Concourse Drive
Suite 204
Linthicum, MD 21090
Phone: 410-694-0500
Fax: 410-694-0596


SEC Filings

DCAI filings with the SEC can be found here. All Fillings are current and the Company is fully reporting.


Disclaimer

SmallCapReview.com feature stock reports are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. For continuing coverage of DCAI, please sign up for our free newsletter. Information contained in this report was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. For more information see our disclaimer section, a link of which can be found on our web site. This document contains forward-looking statements, particularly as related to the business plans of the Company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Actual results may differ materially from the Company's expectations and estimates. The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.

Copyright SmallCapReview.com. All rights reserved. SmallCapReview.com is not a Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. All materials presented on our web site and individual reports released to the public through this web site, e-mail or any other means of transmission are not to be regarded as investment advice and are only for informative purposes. Before making a purchase or sale of any securities featured on our web site or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. As with any stock, companies we select to profile involve a degree of investment risk and volatility. Particularly Small-Caps and OTC-BB stocks. All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies. Past performance of our profiled stocks is not indicative of future results. The accuracy or completeness of the information on our web site or within our reports is only as reliable as the sources they were obtained from. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our web site or within our reports. In order to be in full compliance with the Securities Act  of 1933, Section 17(b), SmallCapReview.com will disclose in it's disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on the SmallCapReview.com web site. SmallCapReview.com has not been compensated for its efforts in presenting the Dialysis Corporation of America profile on its website and distributing it to its database of subscribers. SmallCapReview.com may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report. Information presented on our web site and within our reports contain "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “expects’”, “will,” “anticipates,” “estimates, “believes,” or that by statements indicating certain actions “may,” “could,” or “might” occur.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at: http://www.sec.gov and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com . Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.